BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26787850)

  • 21. Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.
    Huang X; LeDuc RD; Fornelli L; Schunter AJ; Bennett RL; Kelleher NL; Licht JD
    J Biol Chem; 2019 Aug; 294(33):12459-12471. PubMed ID: 31248990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of histone lysine methyl transfer revealed by the structure of SET7/9-AdoMet.
    Kwon T; Chang JH; Kwak E; Lee CW; Joachimiak A; Kim YC; Lee J; Cho Y
    EMBO J; 2003 Jan; 22(2):292-303. PubMed ID: 12514135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
    Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
    J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depletion of Nsd2-mediated histone H3K36 methylation impairs adipose tissue development and function.
    Zhuang L; Jang Y; Park YK; Lee JE; Jain S; Froimchuk E; Broun A; Liu C; Gavrilova O; Ge K
    Nat Commun; 2018 May; 9(1):1796. PubMed ID: 29728617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites.
    Pei H; Zhang L; Luo K; Qin Y; Chesi M; Fei F; Bergsagel PL; Wang L; You Z; Lou Z
    Nature; 2011 Feb; 470(7332):124-8. PubMed ID: 21293379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice.
    Dobenecker MW; Marcello J; Becker A; Rudensky E; Bhanu NV; Carrol T; Garcia BA; Prinjha R; Yurchenko V; Tarakhovsky A
    FEBS Lett; 2020 Oct; 594(20):3324-3337. PubMed ID: 32862441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ISWI chromatin remodeling complexes recruit NSD2 and H3K36me2 in pericentromeric heterochromatin.
    Goto N; Suke K; Yonezawa N; Nishihara H; Handa T; Sato Y; Kujirai T; Kurumizaka H; Yamagata K; Kimura H
    J Cell Biol; 2024 Aug; 223(8):. PubMed ID: 38709169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation.
    Khella MS; Schnee P; Weirich S; Bui T; Bröhm A; Bashtrykov P; Pleiss J; Jeltsch A
    J Biol Chem; 2023 Jun; 299(6):104796. PubMed ID: 37150325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation.
    Patel A; Vought VE; Swatkoski S; Viggiano S; Howard B; Dharmarajan V; Monteith KE; Kupakuwana G; Namitz KE; Shinsky SA; Cotter RJ; Cosgrove MS
    J Biol Chem; 2014 Jan; 289(2):868-84. PubMed ID: 24235145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NSD family of protein methyltransferases in human cancer.
    Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
    Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome.
    Nimura K; Ura K; Shiratori H; Ikawa M; Okabe M; Schwartz RJ; Kaneda Y
    Nature; 2009 Jul; 460(7252):287-91. PubMed ID: 19483677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis.
    Sengupta D; Zeng L; Li Y; Hausmann S; Ghosh D; Yuan G; Nguyen TN; Lyu R; Caporicci M; Morales Benitez A; Coles GL; Kharchenko V; Czaban I; Azhibek D; Fischle W; Jaremko M; Wistuba II; Sage J; Jaremko Ł; Li W; Mazur PK; Gozani O
    Mol Cell; 2021 Nov; 81(21):4481-4492.e9. PubMed ID: 34555356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
    Popovic R; Martinez-Garcia E; Giannopoulou EG; Zhang Q; Zhang Q; Ezponda T; Shah MY; Zheng Y; Will CM; Small EC; Hua Y; Bulic M; Jiang Y; Carrara M; Calogero RA; Kath WL; Kelleher NL; Wang JP; Elemento O; Licht JD
    PLoS Genet; 2014 Sep; 10(9):e1004566. PubMed ID: 25188243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of NSD2-Degraders from Novel and Selective DEL Hits.
    LegaardAndersson J; Christensen J; Kleine-Kohlbrecher D; Vacher Comet I; Fullerton Støier J; Antoku Y; Poljak V; Moretti L; Dolberg J; Jacso T; Jensby Nielsen S; Nørregaard-Madsen M; Franch T; Helin K; Cloos PAC
    Chembiochem; 2023 Dec; 24(24):e202300515. PubMed ID: 37807669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone and DNA binding ability studies of the NSD subfamily of PWWP domains.
    Zhang M; Yang Y; Zhou M; Dong A; Yan X; Loppnau P; Min J; Liu Y
    Biochem Biophys Res Commun; 2021 Sep; 569():199-206. PubMed ID: 34271259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate.
    Li Y; Trojer P; Xu CF; Cheung P; Kuo A; Drury WJ; Qiao Q; Neubert TA; Xu RM; Gozani O; Reinberg D
    J Biol Chem; 2009 Dec; 284(49):34283-95. PubMed ID: 19808676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.
    Qiao Q; Li Y; Chen Z; Wang M; Reinberg D; Xu RM
    J Biol Chem; 2011 Mar; 286(10):8361-8368. PubMed ID: 21196496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specificity.
    Guo HB; Guo H
    Proc Natl Acad Sci U S A; 2007 May; 104(21):8797-802. PubMed ID: 17517655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: An update and perspectives.
    Zhang L; Zha X
    Eur J Med Chem; 2023 Mar; 250():115232. PubMed ID: 36863225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NSD2 methylates AROS to promote SIRT1 activation and regulates fatty acid metabolism-mediated cancer radiotherapy.
    Li X; Song D; Chen Y; Huang C; Liu A; Wu Q; She X; Li K; Wan K; Yu C; Qiu C; Liu L; Wang G; Xu F; Wang J; Hu J
    Cell Rep; 2023 Oct; 42(10):113126. PubMed ID: 37756162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.